Animal models of cystic fibrosis

Journal of Cystic Fibrosis

Volumn 3, Issue SUPPL. 2, 2004, Pages 183-190

  Scholte, Bob J ^a   Davidson, Donald J ^b   Wilke, Martina ^a   De Jonge, Hugo R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal; Cystic fribosis transmembrane conductance regulator; Disease models; Genetics; Intestines; Lung diseases; Mice; Microbiology; Pathology

Indexed keywords

ANIMAL MODEL; CYSTIC FIBROSIS; HOMOLOGOUS RECOMBINATION; MOUSE; MOUSE MUTANT; MOUSE STRAIN; NONHUMAN; PHENOTYPE; REVIEW;

EID: 11044233752     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2004.05.039     Document Type: Article

References (81)

1. Riordan J.R. Rommens J.M. Kerem B. et al. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA Science 245 4922 1989 1066-1073
2. Ledermann B. Embryonic stem cells and gene targeting Exp Physiol 85 6 2000 603-613
3. Snouwaert J.N. Brigman K.K. Latour A.M. et al. An animal model for cystic fibrosis made by gene targeting Science 257 5073 1992 1083-1088
4. Ratcliff R. Evans M.J. Cuthbert A.W. et al. Production of a severe cystic fibrosis mutation in mice by gene targeting Nat. Genet. 4 1 1993 35-41
5. Rozmahel R. Wilschanski M. Matin A. et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor Nat. Genet. 12 3 1996 280-287
6. Hasty P. O'Neal W.K. Liu K.Q. et al. Severe phenotype in mice with termination mutation in exon 2 of cystic fibrosis gene Somat. Cell Mol. Genet. 21 3 1995 177-187
7. Dorin J.R. Dickinson P. Emslie E. et al. Successful targeting of the mouse cystic fibrosis transmembrane conductance regulator gene in embryonal stem cells Transgenic Res. 1 2 1992 101-105
8. O'Neal W.K. Hasty P. McCray P.B.Jr. et al. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus Hum. Mol. Genet. 2 10 1993 1561-1569
9. Davidson D.J. Dorin J.R. The CF mouse: An important tool for studying cystic fibrosis Exp. Rev. Mol. Med 2001 12 March, http://www-ermm.cbcu.com.ac.uk/01002551h.htm
10. Grubb B.R. Boucher R.C. Pathophysiology of gene-targeted mouse models for cystic fibrosis Physiol. Rev. 79 Suppl. 1 1999 S193-S214
11. Colledge W.H. Abella B.S. Southern K.W. et al. Generation and characterization of a delta F508 cystic fibrosis mouse model Nat. Genet. 10 4 1995 445-452
12. Zeiher B.G. Eichwald E. Zabner J. et al. A mouse model for the delta F508 allele of cystic fibrosis J. Clin. Invest. 96 4 1995 2051-2064
13. van Doorninck J.H. French P.J. Verbeek E. et al. A mouse model for the cystic fibrosis delta F508 mutation EMBO J. 14 18 1995 4403-4411
14. French P.J. van Doorninck J.H. Peters R.H. et al. A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo J. Clin. Invest. 98 6 1996 1304-1312
15. Wilke M. Bot A. Jorna H. Rensen S. De Jonge H. Correction of the dF508-CFTR processing defect by low temperature incubation of mouse intestine Pediatr. Pulmonol. Suppl. 25 2003-34
16. Dickinson P. Smith S.N. Webb S. et al. The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics Hum. Mol. Genet. 11 3 2002 243-251
17. Delaney S.J. Alton E.W. Smith S.N. et al. Cystic fibrosis mice carrying the missense mutation G551D replicate human genotype-phenotype correlations EMBO J. 15 5 1996 955-963
18. Du M. Jones J.R. Lanier J. et al. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene J. Mol. Med. 80 9 2002 595-604
19. Haston C.K. McKerlie C. Newbigging S. Corey M. Rozmahel R. Tsui L.C. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice Mamm. Genome 13 11 2002 605-613
20. Bronsveld I. Mekus F. Bijman J. et al. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings J. Clin. Invest. 108 11 2001 1705-1715
21. Hamosh A. King T.M. Rosenstein B.J. et al. Cystic fibrosis patients bearing both the common missense mutation Gly-Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus Am. J. Hum. Genet. 51 2 1992 245-250
22. Bijvelds M. Verkade H. Havinga R. Sinaasappel M. De Jonge H. Both defective lipolysis and impaired fatty acid uptake contribute to fat malabsorption in cystic fibrosis mice Pediatr. Pulmonol. Suppl. 25 2003 340
23. Kent G. Oliver M. Foskett J.K. et al. Phenotypic abnormalities in long-term surviving cystic fibrosis mice Pediatr. Res. 40 2 1996 233-241
24. Ip W.F. Bronsveld I. Kent G. Corey M. Durie P.R. Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice Pediatr. Res. 40 2 1996 242-249
25. Zhou L. Dey C.R. Wert S.E. DuVall M.D. Frizzell R.A. Whitsett J.A. Correction of lethal intestinal defect in a mouse model of cystic fibrosis by human CFTR Science 266 5191 1994 1705-1708
26. De Lisle R.C. Increased expression of sulfated gp300 and acinar tissue pathology in pancreas of CFTR(-/-) mice Am. J. Physiol. 268 4 Pt 1 1995 G717-G723
27. Freedman S.D. Katz M.H. Parker E.M. Laposata M. Urman M.Y. Alvarez J.G. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice Proc. Natl. Acad. Sci. U. S. A. 96 24 1999 13995-14000
28. Gray M.A. Winpenny J.P. Verdon B. McAlroy H. Argent B.E. Chloride channels and cystic fibrosis of the pancreas Biosci. Rep. 15 6 1995 531-541
29. Mearns M. Cystic fibrosis: The first 50 years Dodge J.A. Brock D.J.H. Widdicombe J.H. Cystic fibrosis current topics 1992 217-250 J. Wiley & Sons Chichester
30. Oppenheimer E.H. Esterley J.R. Pathology of cystic fibrosis: review of the literature and comparison with 146 autopsied cases Rosenberg H.S. Bolande R.P. Perspectives in paediatric pathology 1976 241-278 Yearbook Medical New York
31. Govan J.R. Nelson J.W. Microbiology of lung infection in cystic fibrosis Br. Med. Bull. 48 4 1992 912-930
32. Parad R.B. Gerard C.J. Zurakowski D. Nichols D.P. Pier G.B. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype Infect. Immun. 67 9 1999 4744-4750
33. Wilschanski M. Yahav Y. Yaacov Y. et al. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations N. Engl. J. Med. 349 15 2003 1433-1441
34. Boyle M.P. Diener-West M. Milgram L. et al. A multicenter study of the effect of solution temperature on nasal potential difference measurements Chest 124 2 2003 482-489
35. Grubb B.R. Vick R.N. Boucher R.C. Hyperabsorption of Na+ and raised Ca(2+)-mediated Cl- secretion in nasal epithelia of CF mice Am. J. Physiol. 266 5 Pt 1 1994 C1478-C1483
36. MacVinish L.J. Goddard C. Colledge W.H. Higgins C.F. Evans M.J. Cuthbert A.W. Normalization of ion transport in murine cystic fibrosis nasal epithelium using gene transfer Am. J. Physiol. 273 2 Pt 1 1997 C734-C740
37. Bot A. Jorna H. Willemsen R. De Jonge H. Detection of CFTR protein in human and mouse tissues by immunocytochemistry J. Cystic Fibros. 2004 [current issue, B1.4.]
38. Menco B.P. Birrell G.B. Fuller C.M. Ezeh P.I. Keeton D.A. Benos D.J. Ultrastructural localization of amiloride-sensitive sodium channels and Na+,K(+)-ATPase in the rat's olfactory epithelial surface Chem. Senses 23 2 1998 137-149
39. Mall M. Overexpression of ENaC in mouse aiways: A novel animal model for chronic bronchitis and cystic fibrosis lung disease Pediatr. Pulmonol. 121 Suppl. 25 2003 [S7.3]
40. Goddard C.A. Ratcliff R. Anderson J.R. et al. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea Gene Ther. 4 11 1997 1231-1236
41. Zahm J.M. Gaillard D. Dupuit F. et al. Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice Am. J. Physiol. 272 3 Pt 1 1997 C853-C859
42. Cowley E.A. Wang C.G. Gosselin D. Radzioch D. Eidelman D.H. Mucociliary clearance in cystic fibrosis knockout mice infected with Pseudomonas aeruginosa Eur. Respir. J. 10 10 1997 2312-2318
43. Tarran R. Grubb B.R. Parsons D. et al. The CF salt controversy: in vivo observations and therapeutic approaches Mol. Cell 8 1 2001 149-158
44. Borthwick D.W. West J.D. Keighren M.A. Flockhart J.H. Innes B.A. Dorin J.R. Murine submucosal glands are clonally derived and show a cystic fibrosis gene-dependent distribution pattern Am. J. Respir. Cell Mol. Biol. 20 6 1999 1181-1189
45. Thomas G.R. Costelloe E.A. Lunn D.P. et al. G551D cystic fibrosis mice exhibit abnormal regulation of inflammation in lungs and macrophages J. Immunol. 164 7 2000 3870-3877
46. Steagall W.K. Elmer H.L. Brady K.G. Kelley T.J. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression Am. J. Respir. Cell Mol. Biol. 22 1 2000 45-50
47. Kelley T.J. Drumm M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells J. Clin. Invest. 102 6 1998 1200-1207
48. Kent G. Iles R. Bear C.E. et al. Lung disease in mice with cystic fibrosis J. Clin. Invest. 100 12 1997 3060-3069
49. Innes B.A. Dorin J.R. Submucosal gland distribution in the mouse has a genetic determination localized on chromosome 9 Mamm. Genome 12 2 2001 124-128
50. Davidson D.J. Dorin J.R. McLachlan G. et al. Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens Nat. Genet. 9 4 1995 351-357
51. Sajjan U. Thanassoulis G. Cherapanov V. et al. Enhanced susceptibility to pulmonary infection with Burkholderia cepacia in Cftr(-/-) mice Infect. Immun. 69 8 2001 5138-5150
52. Davidson D.J. Webb S. Teague P. Govan J.R.W. Dorin J.R. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase when the level of Cftr is reduced Pathobiology 71 3 2004 152-158
53. Cressman V.L. Hicks E.M. Funkhouser W.K. Backlund D.C. Koller B.H. The relationship of chronic mucin secretion to airway disease in normal and CFTR-deficient mice Am. J. Respir. Cell Mol. Biol. 19 6 1998 853-866
54. Larbig M. Steinmetz I. Reganzerowski A. Tschernig T. Bellman B. Berhard W. et al. Pseudomonas aeruginosa infection in cystic fibrosis: Animal model of the Cftrm1HGU mouse 22nd European Cystic Fibrosis Conference; 1998 1998 140 Berlin
55. McCray P.B.Jr. Zabner J. Jia H.P. Welsh M.J. Thorne P.S. Efficient killing of inhaled bacteria in DeltaF508 mice: Role of airway surface liquid composition Am. J. Physiol. 277 1 Pt 1 1999 L183-L190
56. Schroeder T.H. Reiniger N. Meluleni G. Grout M. Coleman F.T. Pier G.B. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract J. Immunol. 166 12 2001 7410-7418
57. Coleman F.T. Mueschenborn S. Meluleni G. et al. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection Proc. Natl. Acad. Sci. U. S. A. 100 4 2003 1949-1954
58. Grassme H. Kirschnek S. Riethmueller J. et al. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa Science 290 5491 2000 527-530
59. Cannon C.L. Kowalski M.P. Stopak K.S. Pier G.B. Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator Am. J. Respir. Cell Mol. Biol. 29 2 2003 188-197
60. Davidson D.J. Currie A.J. Speert D.P. Pseudomonas aeruginosa infections in individuals with cystic fibrosis: North American perspective Hauser A. Rello J. Severe infections caused by Pseudomonas aeruginosa 2003 71-89 Kluwer Academic Publishing Norwell
61. Gosselin D. Stevenson M.M. Cowley E.A. et al. Impaired ability of Cftr knockout mice to control lung infection with Pseudomonas aeruginosa Am. J. Respir. Crit. Care Med. 157 4 Pt 1 1998 1253-1262
62. Heeckeren A. Walenga R. Konstan M.W. Bonfield T. Davis P.B. Ferkol T. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection with Pseudomonas aeruginosa J. Clin. Invest. 100 11 1997 2810-2815
63. McMorran B.J. Palmer J.S. Lunn D.P. et al. G551D CF mice display an abnormal host response and have impaired clearance of Pseudomonas lung disease Am. J. Physiol. Lung Cell. Mol. Physiol. 281 3 2001 L740-L747
64. Pack R.J. Al-Ugaily L.H. Morris G. Widdicombe J.G. The distribution and structure of cells in the tracheal epithelium of the mouse Cell Tissue Res. 208 1 1980 65-84
65. Grubb B.R. Paradiso A.M. Boucher R.C. Anomolies in ion transport in CF mouse tracheal epithelium Am. J. Physiol. 267 1994 C293-C300
66. Morrison G. Kilanowski F. Davidson D. Dorin J. Characterization of the mouse Beta defensin 1, defb1, mutant mouse model Infect. Immun. 70 6 2002 3053-3060
67. Maxwell A.I. Morrison G.M. Dorin J.R. Rapid sequence divergence in mammalian beta-defensins by adaptive evolution Mol. Immunol. 40 7 2003 413-421
68. Muir A. Soong G. Sokol S. et al. Toll like receptors in normal and cystic fibrosis airway epithelial cells Am. J. Respir. Cell Mol. Biol. 30 6 2003 777-783
69. Hajjar A.M. Ernst R.K. Tsai J.H. Wilson C.B. Miller S.I. Human Toll-like receptor 4 recognizes host-specific LPS modifications Nat. Immunol. 3 4 2002 354-359
70. Koehler D.R. Sajjan U. Chow Y.H. et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia Proc. Natl. Acad. Sci. U. S. A. 100 26 2003 15364-15369
71. Van Heeckeren A.M. Scaria A. Schluchter M.D. Ferkol T.W. Wadsworth S. Davis P.B. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection Am. J. Physiol. Lung Cell. Mol. Physiol. 286 4 2003 L717-L726
72. Peters R.H. van Doorninck J.H. French P.J. et al. Cystic fibrosis transmembrane conductance regulator mediates the cyclic adenosine monophosphate-induced fluid secretion but not the inhibition of resorption in mouse gallbladder epithelium Hepatology 25 2 1997 270-277
73. Castaldo G. Fuccio A. Salvatore D. et al. Liver expression in cystic fibrosis could be modulated by genetic factors different from the cystic fibrosis transmembrane regulator genotype Am. J. Med. Genet. 98 4 2001 294-297
74. Kinnman N. Lindblad A. Housset C. et al. Expression of cystic fibrosis transmembrane conductance regulator in liver tissue from patients with cystic fibrosis Hepatology 32 2 2000 334-340
75. Reynaert I. Van Der Schueren B. Degeest G. et al. Morphological changes in the vas deferens and expression of the cystic fibrosis transmembrane conductance regulator (CFTR) in control, deltaF508 and knock-out CFTR mice during postnatal life Mol. Reprod. Dev. 55 2 2000 125-135
76. Gilljam M. Moltyaner Y. Downey G.P. et al. Airway inflammation and infection in congenital bilateral absence of the vas deferens Am. J. Respir. Crit. Care Med. 169 2 2004 174-179
77. Joo N.S. Krouse M.E. Wu J.V. et al. HCO3- transport in relation to mucus secretion from submucosal glands JOP 2 Suppl. 4 2001 280-284
78. Hug M.J. Bridges R.J. pH regulation and bicarbonate transport of isolated porcine submucosal glands JOP 2 Suppl. 4 2001 274-279
79. Williams S.H. Sahota V. Palmai-Pallag T. Tebbutt S.J. Walker J. Harris A. Evaluation of gene targeting by homologous recombination in ovine somatic cells Mol. Reprod. Dev. 66 2 2003 115-125
80. Li Z. Engelhardt J.F. Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer Reprod. Biol. Endocrinol. 1 1 2003 83
81. The Virtual Repository of Cystic Fibrosis European Network F. Animal and Cellular Models/Vectors 2003 http://central.igc.gulbenkian.pt/cftr/vr/models.html